| scholarly article | Q13442814 |
| P50 | author | Stanley I. Rapoport | Q57269588 |
| P2093 | author name string | Ameer Y Taha | |
| Kaizong Ma | |||
| Jagadeesh S Rao | |||
| Yewon Cheon | |||
| P2860 | cites work | 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia | Q72422975 |
| Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study | Q72496517 | ||
| The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins | Q73142043 | ||
| Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients | Q73521181 | ||
| Critical assessment of in vivo 13C NMR spectroscopy and gas-liquid chromatography in the study of adipose tissue composition | Q77513001 | ||
| Neurobiology of schizophrenia | Q79173267 | ||
| The biochemistry of plasmalogens. I. Isolation and characterization of phosphatidal choline, a pure native plasmalogen | Q79399431 | ||
| Commentary on the effects of a ketogenic diet enriched with omega-3 polyunsaturated fatty acids on plasma phospholipid fatty acid profile in children with drug-resistant epilepsy | Q81240105 | ||
| Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications | Q24682168 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population | Q33588118 | ||
| Brain lipid concentrations in bipolar disorder | Q33653214 | ||
| Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients | Q33751063 | ||
| Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis | Q33839172 | ||
| Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry. | Q33861618 | ||
| The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains | Q33878357 | ||
| Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species | Q33937616 | ||
| Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid | Q33993276 | ||
| Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial | Q34616402 | ||
| From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment | Q34632695 | ||
| Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids | Q34800981 | ||
| Schizophrenia: from phenomenology to neurobiology | Q35146132 | ||
| Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex | Q35218379 | ||
| Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain | Q35284832 | ||
| Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients | Q35306297 | ||
| Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats | Q35308508 | ||
| Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation | Q35529104 | ||
| RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients | Q35662070 | ||
| Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans | Q35742545 | ||
| Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain | Q35844193 | ||
| The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans | Q35866847 | ||
| Fifteen weeks of dietary n-3 polyunsaturated fatty acid deprivation increase turnover of n-6 docosapentaenoic acid in rat-brain phospholipids | Q35946492 | ||
| The synthesis and in vivo pharmacokinetics of fluorinated arachidonic acid: implications for imaging neuroinflammation | Q36433580 | ||
| Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability | Q36518167 | ||
| Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy | Q37029108 | ||
| Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects | Q37131066 | ||
| Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography | Q37222384 | ||
| Changes in brain cholesterol metabolome after excitotoxicity. | Q37688981 | ||
| Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial. | Q38393136 | ||
| Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury | Q39554302 | ||
| The membrane hypothesis of schizophrenia | Q40582385 | ||
| Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. | Q42162908 | ||
| Effects of cholesterol oxidation products on exocytosis. | Q43104546 | ||
| Changes in cholesterol biosynthetic and transport pathways after excitotoxicity | Q43253981 | ||
| Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia | Q43444866 | ||
| Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study | Q43623886 | ||
| Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins | Q44174112 | ||
| Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia | Q44610835 | ||
| Altered thalamic membrane phospholipids in schizophrenia: a postmortem study | Q44953140 | ||
| Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease | Q45295751 | ||
| Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method | Q45295760 | ||
| Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid | Q46423984 | ||
| Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia | Q46539860 | ||
| 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain | Q46728911 | ||
| Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats | Q46808102 | ||
| Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats | Q46915647 | ||
| Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia | Q48165321 | ||
| Alteration to hippocampal shape in cannabis users with and without schizophrenia | Q48271231 | ||
| Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. | Q48271291 | ||
| Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder | Q48522367 | ||
| Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia | Q48630222 | ||
| Fatty acid levels in the brains of schizophrenics and normal controls | Q48639133 | ||
| Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy. | Q48689714 | ||
| Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. | Q48712833 | ||
| Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. | Q48712843 | ||
| The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. | Q48865844 | ||
| Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. | Q48919839 | ||
| Increased brain membrane fluidity in schizophrenia. | Q49118723 | ||
| 7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-κB and Akt pathways. | Q54636992 | ||
| Quantitative analysis of simple lipid classes by thin-layer chromatography | Q68576159 | ||
| P433 | issue | 5 | |
| P921 | main subject | schizophrenia | Q41112 |
| fatty acid | Q61476 | ||
| P304 | page(s) | 636-643 | |
| P577 | publication date | 2013-02-18 | |
| P1433 | published in | Journal of Psychiatric Research | Q6295810 |
| P1476 | title | Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients | |
| P478 | volume | 47 |
| Q37629392 | Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis |
| Q38629703 | Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders. |
| Q97067346 | Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms |
| Q48202362 | Compound-specific isotope analysis resolves the dietary origin of docosahexaenoic acid in the mouse brain. |
| Q37717294 | Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia. |
| Q33668976 | Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools |
| Q35742951 | Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid |
| Q50635567 | GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells. |
| Q35781384 | Impact of a Standard Rodent Chow Diet on Tissue n-6 Fatty Acids, Δ9-Desaturation Index, and Plasmalogen Mass in Rats Fed for One Year. |
| Q91868662 | Impact of diet-derived signaling molecules on human cognition: exploring the food-brain axis |
| Q92465194 | Linoleic acid-good or bad for the brain? |
| Q99409122 | Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression |
| Q101476068 | Lipidomics of the brain, retina, and biofluids: from the biological landscape to potential clinical application in schizophrenia |
| Q39938122 | Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain. |
| Q38764689 | Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective |
| Q34350376 | Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease |
| Q30839707 | Membrane cholesterol access into a G-protein-coupled receptor |
| Q27300848 | Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors |
| Q38267176 | Polyunsaturated fatty acids and their metabolites in brain function and disease. |
| Q37267763 | RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients |
| Q41197076 | Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study |
| Q91251377 | The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial |
| Q64954197 | The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders. |
| Q27319840 | The impact of chronic stress on the rat brain lipidome |
| Q36052708 | The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review. |
| Q98158696 | Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia |
Search more.